Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PTK7 expression is associated with lymph node metastasis, ALK and EGFR mutations in lung adenocarcinomas.

Histology and histopathology - 1 May 2020

Jiang Wei, He Jing, Lv Bihong, Xi Xiaoxiang, He Guangming, He Jingkang

Abstract excerpt

Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer death worldwide. Lung adenocarcinoma is the main tumor type of NSCLC. Recent advances in the molecular characterization and personalized therapies have improved NSCLC patient prognosis. Previous studies showed that protein tyrosine kinase 7 (PTK7) plays an important role in human cancers. However, the role of PTK7 has not been investigated....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cell Adhesion Molecules

Share to ErbB Receptors

Share to Lymphatic Metastasis

Share to Oncogene Proteins, Fusion

Share to Oncogenes

Share to Receptor Protein-Tyrosine Kinases

Source

Identifiers

PMID: 31701509
DOI: 10.14670/HH-18-183

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PTK7 expression is associated with lymph node metastasis, ALK and EGFR mutations in lung adenocarcinomas.PMID 31701509Read ↗

PLEK2 and SCN7A: novel biomarkers of non-small cell lung cancerSemantic proximity Read ↗

PLEK2 and SCN7A: novel biomarkers of non-small cell lung cancerSemantic proximity Read ↗

Comprehensive analysis of prognostic value and immunological implication of YKT6 in lung adenocarcinomaSemantic proximity Read ↗

PSMD7 downregulation suppresses lung cancer progression by regulating the p53 pathwaySemantic proximity Read ↗

Comprehensive analysis identifies YKT6 as a potential prognostic and diagnostic biomarker in lung adenocarcinomaSemantic proximity Read ↗

KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic AdenocarcinomaSemantic proximity Read ↗

Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancerSemantic proximity Read ↗

Comprehensive analysis identifies YKT6 as a potential prognostic and diagnostic biomarker in lung adenocarcinomaSemantic proximity Read ↗

ELK1 Promotes Epithelial‐Mesenchymal Transition and the Progression of Lung Adenocarcinoma by Upregulating B7‐H3Semantic proximity Read ↗

STK11 mutation affects tumor proliferation by impacting CD4+ T cell activity in lung adenocarcinomaSemantic proximity Read ↗

The Predictive Value of PAK7 Mutation for Immune Checkpoint Inhibitors Therapy in Non-Small Cell Cancer.Semantic proximity Read ↗

The Expression of RN7SL494P (7SL) Predicts Nodal Metastasis and Prognosis in Lung AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.